Compare TRST & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TRST | ETON |
|---|---|---|
| Founded | 1902 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 858.9M | 689.8M |
| IPO Year | 1994 | 2018 |
| Metric | TRST | ETON |
|---|---|---|
| Price | $50.25 | $32.76 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $39.33 |
| AVG Volume (30 Days) | 67.4K | ★ 373.4K |
| Earning Date | 04-21-2026 | 05-14-2026 |
| Dividend Yield | ★ 3.25% | N/A |
| EPS Growth | ★ 26.46 | N/A |
| EPS | ★ 0.91 | 0.05 |
| Revenue | N/A | ★ $79,950,000.00 |
| Revenue This Year | N/A | $40.90 |
| Revenue Next Year | N/A | $47.23 |
| P/E Ratio | $55.44 | ★ N/A |
| Revenue Growth | N/A | ★ 104.94 |
| 52 Week Low | $30.17 | $13.09 |
| 52 Week High | $50.52 | $35.66 |
| Indicator | TRST | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 67.76 | 63.63 |
| Support Level | $41.96 | $16.17 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.89 | 1.90 |
| MACD | 0.11 | 0.28 |
| Stochastic Oscillator | 82.95 | 62.14 |
Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The company derives revenue from the business of Banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey, and Vermont.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.